New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2014
07:15 EDTEVGNEvogene launches target discovery platform for novel herbicides
Evogene announced a key milestone in its discovery program for novel chemical herbicides with the launch of PoinTar, a computationally based target discovery platform for novel herbicides. Targets are key molecules, responsible for essential biological processes in weeds, which have the potential to be chemically inhibited to cause weed death. The launch of the PoinTar platform is the first key milestone in the program. An important feature of the new platform, in addition to the predictive discovery of potential targets, is the ability to prioritize the resulting predictions for proteins on the basis of structural information such as ‘drugability’, that is the ability of the predicted target to interact with a chemical molecule. In addition, PoinTar is able to identify non-coding RNAs as potential targets, adding a substantial new class of overlooked molecules to the discovery process. The combination of these two computationally based features is anticipated to provide a unique and effective target discovery capability. The remaining key development milestone for the establishment of Evogene's herbicide discovery capability is the completion of a second, complementary platform for the discovery of chemical molecules that are designed to inhibit the activity of targets discovered using the PoinTar platform. These chemical molecules will then serve as the active ingredients for the final herbicide product.
News For EVGN From The Last 14 Days
Check below for free stories on EVGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
07:12 EDTEVGNEvogene announces amendment to Bayer wheat agreement
Subscribe for More Information
July 22, 2014
07:10 EDTEVGNEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use